top of page

Data analysis B2B

Turn complex biomedical data into actionable insights

Advanced analysis for high-dimensional biomedical datasets

Biomedical data are becoming increasingly complex. We measure hundreds or thousands of variables, from genomics and imaging to biomarkers, but often we have only a limited number of patients or samples. This makes reliable analysis and personalized medicine challenging.

What can SaddlePoint help you investigate

research_questions_hires.png

A simple structured process

We start with your data and your question and guide you through a clear process from initial analysis to deeper understanding. 

process_steps_bright.png

What you receive

A clear, focused report with the insights that matter to you.

  • Relevant patient subgroups

  • Predictive and risk models

  • Treatment-response insights

  • Biomarker-related findings

  • Model performance and validation measures

  • Visualisations and key patterns

  • Interpretation of results

  • Recommendations for follow-up analyses

coverreport.jpg

Built for complex biomedical data

Saddlepoint is particularly suited to datasets where the conventional approaches can struggle

  • High-dimensional data

    • Large numbers of variables, biomarkers or measurements

  • Complex patient populations

    • Where meaningful subgroups or response heterogeneity may exist.​

  • Limited sample size

    • Complex datasets where the number of variables is large relative to the number of patients.

  • Multiple potential predictors

    • Identifying robust and relevant signals is more important than simply finding correlations.​

Brainstormen

A low-risk way to explore your data

Do you have a dataset with a question you were unable to answer? And you don’t want to commit to a long-term software implementation before understanding it’s potential value.  Talk to Saddle Point Science about your data and explore how we can help!

​

If the results demonstrate value, we can continue with a more comprehensive SPS validation and discuss longer-term software use.

bottom of page